Infinity Pharmaceuticals, Inc. (NASDAQ:INFI)

CAPS Rating: 1 out of 5

The Company's mission is to discover, develop, and deliver to patients medicines for the treatment of cancer and related conditions.

Recs

0
Player Avatar pjani06 (45.90) Submitted: 7/23/2009 6:56:34 PM : Outperform Start Price: $8.13 INFI Score: +20.03

outperform. company is HIGH in cash. not terribly overvalued, and is likely to kill S&P 500 where it is at today's levels.
additionally these companies are not within the financials nor energy sectors.

Report this Post Reply

Featured Broker Partners


Advertisement